What Is PV?
Polycythemia vera (polly-sigh-THEE-me-ah-VAIR-Ah), or PV, is a rare, chronic blood cancer where the bone marrow produces too many red blood cells. You may also have too many white blood cells and platelets (blood clotting cells) in your blood, but having too many red blood cells causes most of the problems associated with this condition. PV is part of a group of diseases called myeloproliferative neoplasms, or MPNs.
Too many red blood cells can cause the blood to thicken. Thicker blood doesn’t flow normally through arteries and veins. Increased blood thickness and decreased blood flow, as well as abnormalities in your platelets and white blood cells, may increase your risk of blood clots. Blood clots can cause a stroke, heart attack, or blockage of an artery in your lungs or in a vein deep within a muscle in your arms or legs.
What the EKG had, in fact, detected, was my heart struggling to push my abnormally thick blood through my body. –Matt W, Community Voice Champion
Can PV Transform Into Other Blood Diseases?
PV usually develops slowly. But as the symptoms get worse, they can take a toll on you and affect your daily life. In a very small number of people, PV leads to other blood diseases, such as myelofibrosis (MF) (a disease in which scar tissue develops in the bone marrow) or leukemia.
How Common Is PV?
Approximately 100,000 people in the United States are living with this rare disease. PV can occur at any age, but it is more common in people over 60 years of age. It affects slightly more men than women.
How Is It Managed?
Management may include low-dose aspirin. Phlebotomy, a procedure that helps lower blood cell counts by removing blood from the body, may also be used. Patients who have difficulty with phlebotomy, who have an enlarged spleen, who experience severe PV-related symptoms, or who continue to have elevated blood counts may have other care management approaches, including but not limited to chemotherapy drugs.
What Is the Prognosis for People With PV?
There is no single, one-size-fits-all answer regarding the life expectancy associated with PV. Each individual journey is unique, and how PV may change over time will vary from person to person.
PV can often be effectively managed for a long period of time with ongoing medical supervision and an individualized management plan. The median survival for people with PV can be up to 20 years or longer, depending on the individual and his or her specific management approach. However, PV can worsen (progress), and in some cases, transform into myelofibrosis.
Your specific medical situation should be evaluated by your Healthcare Professional, who is the best source of information about life expectancy with PV.
Speak Up—and Spell Out How Your PV Makes You Feel
As you work together with your Healthcare Professional to understand and assess your PV, it’s important to be aware of how you feel and how this disease affects your daily life, routines, and activity levels. Your symptoms, blood counts, even your feelings can help you identify where you are on your journey with PV—and when it may be time to have a conversation with your MPN healthcare team.
Regularly evaluating your PV may help you recognize when something isn’t right. This can empower you to communicate with your Healthcare Professional about how your PV is affecting you and how it may be changing over time so that you can work together to manage your condition.